Description of Pharmacogenomic Testing Among Patients Admitted to the Intensive Care Unit After Cardiovascular Surgery.

Pamela E PetersonWayne T NicholsonAnn M MoyerChristopher J ArendtNathan J SmischneyTroy G SeelhammerCatherine A KreckeRory M HaneyElissa J YawLinda L Chlan

Published in: Journal of intensive care medicine (2020)

A significant portion of patients had identified genetic variants that may warrant changes in medication management during and after CV-ICU stay. It remains to be seen if PGx testing leads to improvements in ICU patient outcomes.

Keyphrases

end stage renal disease
intensive care unit
ejection fraction
chronic kidney disease
minimally invasive
newly diagnosed
healthcare
peritoneal dialysis
emergency department
atrial fibrillation
percutaneous coronary intervention
adverse drug